Competitive Generic Therapies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 5, 2022
January 11, 2023
402bfb2a-4126-427d-9a19-4507e22c6b0e
Related Documents
Controlled Correspondence Related to Generic Drug Development
Guidance DocumentMarch 18, 2024Center for Drug Evaluation and Research
Orange Book Questions and Answers Guidance for Industry: Guidance for Industry
Guidance DocumentJuly 22, 2022Center for Drug Evaluation and Research
Good ANDA Submission Practices Guidance for Industry
Guidance DocumentJanuary 26, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.